Phase II trial of carboplatin and infusional cyclosporine in platinum-resistant recurrent ovarian cancer

Author： Morgan Robert   Synold Timothy   Gandara David   Muggia Franco   Scudder Sidney   Reed Eddie   Margolin Kim   Raschko James   Leong Lucille   Shibata Stephen   Tetef Merry   Vasilev Steven   McGonigle Kathryn   Longmate Jeff   Yen Yun   Chow Warren   Somlo George   Carroll Mary   Doroshow James  

Publisher： Springer Publishing Company

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.54, Iss.4, 2004-10, pp. : 283-289

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Altretamine (Hexamethylmelamine) in Platinum-Resistant and Platinum-Refractory Ovarian Cancer: A Gynecologic Oncology Group Phase II Trial

By Markman M.   Blessing J.A.   Moore D.   Ball H.   Lentz S.S.  

Gynecologic Oncology, Vol. 69, Iss. 3, 1998-06 ,pp. : 226-229

Elsevier

Access to resources Recommend Favorite

Evaluation of Cisplatin and Cyclosporin A in Recurrent Platinum-Resistant Ovarian Cancer: A Phase II Study of the Gynecologic Oncology Group

By Manetta A.   Blessing J.A.   Hurteau J.A.  

Gynecologic Oncology, Vol. 68, Iss. 1, 1998-01 ,pp. : 45-46

Elsevier

Access to resources Recommend Favorite

Phase II Study of Gemcitabine and Docetaxel in Recurrent Platinum Resistant Ovarian Cancer

By Garcia Agustin A.   Yessaian Anne   Pham Huyen   Facio Grace   Muderspach Laila   Roman Lynda  

Cancer Investigation, Vol. 30, Iss. 4, 2012-04 ,pp. : 295-299

Informa Healthcare

Access to resources Recommend Favorite

A pilot study of whole body hyperthermia and carboplatin in platinum-resistant ovarian cancer

By Westermann A.M.   Grosen E.A.   Katschinski D.M.   Jager D.   Rietbroek R.   Schink J.C.   Tiggelaar C.L.   Jager E.   Zum Vorde sive Vording P.   Neuman A.   Knuth A.   Van Dijk J.D.P.   Wiedemann G.J.   Robins H.I.  

European Journal of Cancer, Vol. 37, Iss. 9, 2001-06 ,pp. : 1111-1117

Elsevier

Access to resources Recommend Favorite

Phase II study of cetrorelix, a luteinizing hormone-releasing hormone antagonist in patients with platinum-resistant ovarian cancer

By Garcia Agustin  

The Women's Oncology Review, Vol. 4, Iss. 1, 2004-01 ,pp. : 45-46

Informa Healthcare

Access to resources Recommend Favorite